ACW actinogen medical limited

News: ACW Actinogen Announces Further Positive Results In The Xancidd Phase 2A Trial

  1. 193,698 Posts.
    lightbulb Created with Sketch. 2825

    Aug 26 (Reuters) - Actinogen Medical Ltd (ACW) :

    • ACTINOGEN ANNOUNCES FURTHER POSITIVE RESULTS ON DEPRESSION IN THE XANCIDD PHASE 2A TRIAL
    • ACTINOGEN MEDICAL LTD -INTERIM DATA ARE ANTICIPATED IN MID 2025
 
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
(20min delay)
Last
2.7¢
Change
-0.001(3.57%)
Mkt cap ! $85.73M
Open High Low Value Volume
2.9¢ 2.9¢ 2.7¢ $76.07K 2.734M

Buyers (Bids)

No. Vol. Price($)
5 725877 2.7¢
 

Sellers (Offers)

Price($) Vol. No.
2.8¢ 535081 2
View Market Depth
Last trade - 16.10pm 12/09/2025 (20 minute delay) ?
ACW (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.